Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System.
Pruitt, Sandi L; Werner, Claudia L; Borton, Eric K; Sanders, Joanne M; Balasubramanian, Bijal A; Barnes, Arti; Betts, Andrea C; Skinner, Celette Sugg; Tiro, Jasmin A.
Cancer Epidemiol Biomarkers Prev
; 27(12): 1398-1406, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30185535
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Two Basic Scientists Walk into a Translational Space.
[Precision screening and treatment of human papilloma virus related cervical cancer].
Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.
Surgical treatment of stage IA2 cervical cancer.
A Prize for Cancer Prevention.
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.
Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Variables socio-sanitarias asociadas al uso adecuado de la citología cervico-uterina en mujeres del área rural-Cartagena